• 11 July, 2013
  • Full story
  • 22 April, 2013
  • The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.
    Full story
  • 11 October, 2012
  • The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.
    Full story
  • ISSCR Emphasizes Rigorous Oversight for Application of Stem Cell-Based Treatments

  • 12 April, 2012
  • The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.
    Full story
  • ISSCR Statement on Advocate General Opinion in Case C-34/10, Brüstle v Greenpeace eV

  • 12 April, 2011
  • The ISSCR reiterates its statement of April below in support of hESC research and policies that promote the responsible development of new therapies.
    Full story
  • ISSCR Comments on NIH Draft Guidelines for Embryonic Stem Cell Funding

  • 24 September, 2009
  • In the interest of improving world health we urge the NIH to open discussions on funding research carried out with human pluripotent stem cell lines derived from sources other than excess reproductive IVF embryos, including SCNT embryos, if they become available and are derived under rigorous ethical standards.
    Full story
  • Stem Cell Society Leaders Receive Nation's Top Science Awards

  • 23 September, 2009
  • 9/23/2009 5:00:00 AM

    The ISSCR congratulates two board members who were named recipients of two of the nation’s top science awards, Shinya Yamanaka, MD, PhD (Kyoto University), and Elaine Fuchs, PhD (Rockefeller University).
    Full story
  • Tumors After Attempted Stem Cell Therapy Highlight Importance of Rigorous Standards Before Clinical Treatment

  • 4 March, 2009
  • 3/4/2009 6:00:00 AM

    The ISSCR is concerned and saddened by the recent report of nervous system tumors that developed in a child who had previously received injections of cell preparations referred to as “neural stem cells.” This illustrates the concerns that prompted the ISSCR to develop Guidelines for the Clinical Translation of Stem Cells, released in December 2008.
    Full story
  • ISSCR Scientists Elated for Future of Human Embryonic Stem Cell Research After Obama Lifts Funding Ban

  • 3 March, 2009
  • The ISSCR applauds President Barack Obama’s decision to expand federal funding for human embryonic stem cell research by rescinding the policy of Aug. 9, 2001, which restricted federally-funded researchers to using only the small number of cell lines created before that date.
    Full story
  • Scientists See Progress in FDA Stem Cell Trial Approval

  • 6 January, 2009
  • 1/6/2009 6:00:00 AM

    The ISSCR shares in the excitement generated by the U.S. Food and Drug Administration‘s landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.
    Full story
  • Scientists Urge President-Elect Obama to Restore U.S. Funding of Stem Cell Research

  • 6 November, 2008
  • The ISSCR, representing the world’s leading stem cell scientists, urges President-Elect Barack Obama to restore federal funding for embryonic stem cell research in the first 100 days of his presidency.
    Full story
  • ISSCR Applauds Outcome of Proposal 2 Advancing Stem Cell Research

  • 5 November, 2008
  • On Tuesday, Michigan voters were asked to support Michigan’s Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases. The International Society for Stem Cell Research (ISSCR), representing some of the world’s leading stem cell researchers, along with other leading scientists works to support all types of stem cell research. The vote was 53% in favor and 47% opposed to Proposal 2.
    Full story
  • Stem Cell Science Experts Release Letter Urging U.S. Commitment to All Avenues of Stem Cell Research

  • 22 September, 2008
  • The ISSCR joined with other leading scientists today to issue an open letter to reiterate the urgent need for U.S. support for all types of stem cell research. The Society is the world’s preeminent professional organization of stem cell researchers.
    Full story
  • Letter of support for the November 2008 Michigan ballot initiative to support embryonic stem cell research

  • 5 September, 2008
  • The ISSCR and the ISSCR Government Affairs Committee writes to offer support of your important initiative to amend the constitution of the state of Michigan to permit the derivation of embryonic stem cells from human embryos using approaches that are being used throughout much of the rest of the world.
    Full story
  • ISSCR Marks First Annual Global Forum

  • 24 March, 2008
  • The ISSCR today holds its inaugural Global Forum, bringing together the newly established ISSCR Global Advisory Council with members of the ISSCR leadership and other outside experts to survey the current state of stem cell science, to evaluate the opportunities and challenges facing the field and to develop strategic directions for the ISSCR.
    Full story
  • Letter to German Government supporting changes to the Stem Cell Act, 2002

  • 7 March, 2008
  • As representatives of the Board of Directors of the International Society for Stem Cell Research (ISSCR), we urge you to accept the recent recommendations of the German Research Foundation (DFG) regarding revisions to the 2002 Stem Cell Act.
    Full story
  • ISSCR Statement on the Stem Cell Initiatives Announced in President Bush’s State of the Union Address

  • 29 January, 2008
  • In his State of the Union address, President Bush acknowledged the landmark achievement of stem cell scientists who have demonstrated for the first time that human skin cells can be converted into induced pluripotent stem cells (iPS cells), which behave like embryonic stem cells. The ISSCR applauds the President’s direction to Federal agencies to provide additional funding for this important research.
    Full story
    View All ISSCR News